What is the drug class of Synjardy (empagliflozin and metformin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the recommended dosing and monitoring for a combination of metformin (biguanide) and an SGLT2 (sodium-glucose cotransporter 2) inhibitor, such as empagliflozin (Jardiance) or canagliflozin (Invokana), in patients with type 2 diabetes?
What is the recommended rate for increasing Synjardy (empagliflozin and metformin) from once daily to twice daily?
How to adjust insulin glargine (Lantus) and carbohydrate ratio when adding metformin (Glucophage) and empagliflozin (Jardiance) to a patient's regimen?
What adjustments should be made to the treatment plan for a patient with hyperglycemia, currently taking Jardiance (Empagliflozin) 25mg and Janumet (Sitagliptin/Metformin) 50-1000mg?
Can I split my Synjardy (empagliflozin and metformin) dose?
What are the treatment options for male genital warts?
What is the calcium level threshold for admitting a patient with hypocalcemia after a post-operative thyroidectomy?
Until when should doxylamine be given for nausea and vomiting of pregnancy?
What is the mechanism of action (MOA) and uses of doxylamine?
How soon before surgery should Synjardy (empagliflozin and metformin) be discontinued?
What is the most likely diagnosis for a 63-year-old patient with a history of smoking (15 pack-years), family history of intestinal polyposis, unintentional weight loss, abdominal pain, constipation, and diarrhea, with lab results showing anemia (low Hemoglobin (Hb)) and elevated white blood cell count (leucocitos), and what is the associated risk factor and indicated treatment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.